CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc. (Nasdaq: CERU) today announced the pricing of an underwritten public offering of 5,840,000 shares of its common stock at a public offering price of $6.00 per share, before underwriting discounts. All of the shares in the offering are being offered by Cerulean. In addition, Cerulean has granted the underwriters an option for a period of 30 days to purchase up to 876,000 additional shares of common stock at the public offering price, less underwriting discounts.
Help employers find you! Check out all the jobs and post your resume.
